z-logo
open-access-imgOpen Access
SURGICAL SITE INFECTION;
Author(s) -
Aftab Ahmed Memon,
Aasiya Shaikh,
Riaz A. Memon,
Afzal Junejo
Publication year - 2019
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2019.26.04.3355
Subject(s) - medicine , surgery , acute appendicitis , surgical site infection , wound infection , presentation (obstetrics) , surgical wound , infection control , iodine , clinical trial , randomized controlled trial , materials science , metallurgy
Objectives: Efficacy of postoperative Povidone-Iodine pro­phylaxis and surgical site infection in appendectomy surgery. Study Design: Randomized clinical trial. Place and Duration: Department of Surgery, Liaquat University Hospital Jamshoro/Hyderabad from March 2016 to November 2017. Subjects and Methods: Diagnosed cases of acute appendicitis with classical clinical presentation were included in the study protocol. 60 patients were those, who were applied 1% povidone-iodine solution (cases) to wound post operatively versus 60 patients (control) were those in whom wound not irrigated with Povidone- Iodine. Ethical approval and consent were taken. Data was noted in a proforma and analyzed on SPSS 22.0 (P≤0.05). Results: Age (mean ± SD) in control and cases was observed as 25.5 ± 8.5 and 24.5 ± 9.5 years respectively (P=0.76). Male and female were noted as 43 (%) and 17 (%) & 45 (%) and 15 (%) in control and cases respectively (P >0.05). Wound healing score by Southampton classification of wound healing shows lesser frequency of surgical site infection in cases compared to controls (P <0.05). Grade 4 pus discharging wound infection was noted in 2 (3.33%) control versus 3 (5.0%) in cases (P=0.021). Conclusion: It is concluded that the 1% Povidone- Iodine solution is effective in preventing the post appendectomy surgical site infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here